Business
Preliminary Results Date
Preliminary Results Date.
About this update from Genedrive Plc
[{"type":"text","content":"\n \nRNS Number : 4173P Epistem Holdings plc 01 October 2013 \n \n\n \n \n \n \n \nPreliminary Results Date\n \n \n1st October 2013\n \n \nEpistem Holdings Plc (LSE: EHP), the biotechnology and personalised medicine company will be announcing its preliminary results for the year ended 30 June 2013 on Tuesday, 22 October 2013. \n \nAn analysts' meeting will be held at the London Stock Exchange, 10 Paternoster Square, London EC4M 7LS in Forum 3 at 9.30am. Due to the security measures in place at the LSE, please ensure you arrive at 9am for an on time start.\n \nIf you would like to attend, please contact either Anna Dunphy or Mike Wort at Walbrook PR.\n \n \n \n \n\n\n\n\nEpistem Plc\n\n\n\n\n\n\n\n\n\n\nMatthew Walls \n\n\nChief Executive Officer\n\n\n+44 (0) 7887 501998\n\n\n\n\nJohn Rylands \n\n\nFinance Director\n\n\n+44 (0) 161 606 7244\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeel Hunt LLP \n\n\n\n\n\n\n\n\n\n\nJames Steel\n\n\n\n\n\n+44 (0) 207 418 8900\n\n\n\n\nVijay Barathan\n\n\n\n\n\n+44 (0) 207 418 8900\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR\n\n\n\n\n\n\n\n\n\n\nMike Wort / Anna Dunphy\n\n\n\n\n\n+44 (0) 20 7933 8780\n\n\n\n\n \n \n \nNotes to Editors: \n \nAbout Epistem \n \nEpistem is a biotechnology and personalised medicine company commercialising its expertise in epithelial stem cells and pharmacogenomics in the areas of oncology, gastrointestinal, dermatological and infectious disease. \nEpistem develops innovative therapeutics, biomarkers and diagnostics alongside providing preclinical services to drug development companies. Epistem's core expertise is focused on the regulation of adult stem cells located in epithelial tissue which includes the gastrointestinal tract, skin, hair follicles, breast and prostate. Epistem also has a range of proprietary amplification (RNA and DNA) technologies for use in drug discovery, development and diagnostics. \n \n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END NORLLFIFIVLLIIV\n ","length":6607,"tagName":"div"}]